100 Bayer Road
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.
Bayer’s culture supports its employees through personal development opportunities, international and diverse teams, regular feedback, and state-of-the-art benefits. At Bayer, you have the opportunity to be part of a company where we value the passion of our employees to innovate, and give them the power to change. For further information visit our website at www.career.bayer.us
Passion to innovate | Power to change
394 articles with Bayer
The company is addressing the FDA’s complaints regarding manufacturing practices, which stem from a routine inspection in January,
Bayer announced today that Dan Childs, award-winning medical journalist and Managing Editor of the ABC News Medical Unit, is joining the company as Director of External Communications responsible primarily for U.S. Media Relations.
During an international conference in Davos, Switzerland, President Donald Trump sat down with the leaders of several European life science companies to encourage more investment in the United States.
The mom of three is now the seventh Scottish woman to join a group legal action against Bayer.
In an effort to help veterans excel in civilian life, Bayer and VETTED today unveiled a new partnership in which Bayer will serve as title sponsor of VAMP at the University of Texas and Texas A&M University.
These are tough times for Teva.
Bayer Release: Updated Larotrectinib Pediatric Phase I Clinical Trial Data Demonstrates Response in TRK Fusion Cancers
These data are being presented today at the AACR Special Conference on Pediatric Cancer Research in Atlanta.
Bayer and the Broad Institute of MIT and Harvard Expand Partnership to Advance Drug Discovery Research for Novel Cancer Treatments
Bayer and the Broad Institute of MIT and Harvard announced today that they have extended their multi-disciplinary research partnership by an additional five years, to develop and advance novel cancer treatments.
Bayer's Phase III Study With Amikacin Inhale in Intubated And Mechanically Ventilated Patients Wi...
11/27/2017The primary endpoint, as well as secondary endpoints were similar in both treatment arms, and were therefore not met.
Loxo Oncology struck a deal with Bayer to develop and commercialize two cancer therapies in a deal that could be worth up to $1.55B.
Compugen today announced that it is advancing COM902, its lead anti-TIGIT antibody, into manufacturing in anticipation of filing an IND in 2019.
The makers of hydraSense are pleased to introduce the hydraSense daily nasal care line to the U.S. market.
The FDA has accepted Bayer's BLA filing for BAY94-902 for the treatment of hemophilia A in adults and adolescents 12 years of age and over.
Bayer to Present Pulmonary Arterial Hypertension Data at the 2017 Annual Meeting of the American College of Chest Physicians
Bayer announced today that data from its pulmonary disease franchise will be presented in scientific sessions at the 2017 annual meeting of the American College of Chest Physicians (CHEST 2017), October 28 - November 1 in Toronto, Canada.
Bayer And The Society For Reproductive Investigation Collaborate To Advance Women's Healthcare Research